HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zheng, W. Articles by She, J.-X. Search for Related Content PubMed PubMed Citation Articles by Zheng, W. Articles by She, J.-X. Social Bookmarking                What's this?

Genetic Association Between a Lymphoid Tyrosine Phosphatase (PTPN22) and Type 1 Diabetes

From the Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta, Georgia

The lymphoid-specific phosphatase (LYP) encoded by PTPN22 is involved in preventing spontaneous T-cell activation by dephosphorylating and inactivating T-cell receptor-associated Csk kinase. We have genotyped 396 type 1 diabetic patients and 1,178 control subjects of Caucasian descent from north central Florida and report a strong association between type 1 diabetes and a polymorphism (R620W) in the PTPN22 gene. The homozygous genotype for the T allele encoding the 620W residue is associated with an increased risk for developing type 1 diabetes (odds ratio [OR] = 3.4, P < 0.008), and the heterozygous genotype C/T had an OR of 1.7 (P = 6 x 10^–6). The C/C homozygous genotype is protective against type 1 diabetes (OR = 0.5, P = 6 x 10^–6). Furthermore, transmission disequilibrium analysis of 410 affected sibpair and simplex families of Caucasian descent indicated that the type 1 diabetes-associated T allele is transmitted more often (57.2%) than randomly expected (P < 0.003). Together with previous reports of the association between PTPN22 and type 1 diabetes, as well as rheumatoid arthritis and systemic lupus erythematosus, these results provide compelling evidence that LYP is a critical player in multiple autoimmune disorders.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. J. Smyth, J. D. Cooper, J. M.M. Howson, N. M. Walker, V. Plagnol, H. Stevens, D. G. Clayton, and J. A. Todd PTPN22 Trp620 Explains the Association of Chromosome 1p13 With Type 1 Diabetes and Shows a Statistical Interaction With HLA Class II Genotypes Diabetes, June 1, 2008; 57(6): 1730 - 1737. [Abstract] [Full Text] [PDF]

				C. Chelala, S. Duchatelet, M.-L. Joffret, R. Bergholdt, D. Dubois-Laforgue, P. Ghandil, F. Pociot, S. Caillat-Zucman, J. Timsit, and C. Julier PTPN22 R620W Functional Variant in Type 1 Diabetes and Autoimmunity Related Traits Diabetes, February 1, 2007; 56(2): 522 - 526. [Abstract] [Full Text] [PDF]

				Y. H. Lee, Y. H. Rho, S. J. Choi, J. D. Ji, G. G. Song, S. K. Nath, and J. B. Harley The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis Rheumatology, January 1, 2007; 46(1): 49 - 56. [Abstract] [Full Text] [PDF]

				S. Onengut-Gumuscu, J. H. Buckner, and P. Concannon A Haplotype-Based Analysis of the PTPN22 Locus in Type 1 Diabetes. Diabetes, October 1, 2006; 55(10): 2883 - 2889. [Abstract] [Full Text] [PDF]

				A. Hinks, J. Worthington, and W. Thomson The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis Rheumatology, April 1, 2006; 45(4): 365 - 368. [Full Text] [PDF]